Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03385083 · ClinicalTrials.gov registry record · NA
Clinical Outcomes in Chronic Low Pain Back Utilizing Activity Trackers
A NA study, sponsored by New York Institute of Technology.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03385083: Clinical Trial NA study, sponsored by New York Institute of Technology.
NCT03385083 is a NA study that was terminated before completion, run by New York Institute of Technology. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03385083, a NA study, was terminated before completion, sponsored by New York Institute of Technology.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a randomized controlled study to assess the effects of activity monitors, with telehealth follow ups, on the treatment of chronic low back pain subjects.
Primary Outcome
Back pain assessment tool
Interventions
- BEHAVIORAL Step count monitoring with consulting
- BEHAVIORAL Step count monitoring without consultation
- DEVICE Fitbit tracker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-05-12 |
| Est. Completion | 2018-05-01 |
| Phase | NA |
Why NCT03385083 stopped before completion
NCT03385083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Step count monitoring with consulting is the first listed.
NCT03385083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03385083 about?
NCT03385083 is a clinical study titled "Clinical Outcomes in Chronic Low Pain Back Utilizing Activity Trackers". This is a randomized controlled study to assess the effects of activity monitors, with telehealth follow ups, on the treatment of chronic low back pain subjects.
What is the current status of trial NCT03385083?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-05-12. Estimated completion is 2018-05-01.
What interventions are being tested in trial NCT03385083?
The interventions under investigation include: Step count monitoring with consulting (BEHAVIORAL), Step count monitoring without consultation (BEHAVIORAL), Fitbit tracker (DEVICE).
Who is sponsoring clinical trial NCT03385083?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03385083's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI